Hippocratic AI, a healthcare-focused AI startup, has raised $141 million in a Series B funding round led by Kleiner Perkins, elevating its valuation to $1.64 billion. The funding, secured just nine months after its Series A round, brings the company’s total funding to $278 million. Key investors include General Catalyst, Premji Invest, Andreessen Horowitz (A16z), NVIDIA, and Universal Health Services. The company plans to utilize the capital to expand into new verticals such as pharmaceuticals and payors and to extend its reach across regions like EMEA, Southeast Asia, and Latin America.
Hippocratic AI’s advancements include its Polaris 2.0 Large Language Model, featuring 3.7 trillion parameters and support for 14 languages, designed to deliver safe and intelligent healthcare solutions. The company has also launched an AI Agent App Store, allowing licensed clinicians to create and customize AI agents for specific healthcare use cases. Co-founded by CEO Munjal Shah and a team of experts from leading healthcare and tech institutions, the startup is committed to driving global healthcare improvements by blending cutting-edge AI with clinical expertise. Its focus on safety and clinician-driven innovation positions it as a leader in transforming healthcare delivery worldwide.
Read the full article here